Skip to site content
U.S. Department of Health and Human Services
Clinical Reporting System (CRS)

CRS 2023 (v23.0)

CRS VERSION 23.0

CRS Version 23.0 is expected to be released in February 2023.

View the CRS 2023 (v23.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 1.4 MB]

View the CRS 2023 (v23.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 966 KB]

Key enhancements included in CRS Version 23.0 are shown below.

  • Logic Changes to National GPRA/GPRAMA Report Measures 
    • GPRA Developmental Measures: 
      • Added the following GPRA Developmental topic: 
        • Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes 
      • Removed the following GPRA Developmental topics:
        • Diabetes: Blood Pressure Control
        • Screening, Brief Intervention, and Referral to Treatment (SBIRT)
      • Removed measures from Adult Immunizations topic and moved to GPRA report. 
      • Updated codes and/or logic in the following measures: Childhood Immunizations; Suicide Risk Assessment; Appropriate Medication Therapy after a Heart Attack; HIV Screening; HIV Quality of Care; Sexually Transmitted Infection (STI) Screening; Proportion of Days Covered by Medication Therapy; Concurrent Use of Opioids and Benzodiazepines.
    • Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: (1) Removed POV E78.00 from hypercholesterolemia definition. (2) Changed ASCVD definition to an active diagnosis or an ASCVD procedure ever. (3) Removed pregnancy as a denominator exclusion. (4) Added denominator exception for patients with documentation of a medical reason for not being prescribed statin therapy. (5) Updated hospice indicator and palliative care definitions. (6) Updated medication taxonomy BGP PQA STATIN MEDS.
    • Influenza: Changed measure for patients 18 years and older to a GPRAMA measure. 
    • Adult Immunizations: (1) Updated age ranges. (2) Updated pneumococcal measures and logic to match previous GPRA Developmental measures. (3) Removed Zostavax vaccine from logic and measures. 
    • Childhood Immunizations: Removed POV codes 042.0 through 044.9 and R75 from HIV definition. 
    • Cancer Screening: Mammogram Rates: Added POV code Z12.31 and CPT codes 77061 through 77063 and G0279 to mammogram definition. 
    • Screening, Brief Intervention, and Referral to Treatment (SBIRT): Updated measures to include telemedicine visits (previous GPRA Developmental logic). 
    • Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: (1) Removed POV E78.00 from hypercholesterolemia definition. (2) Changed ASCVD definition to an active diagnosis or an ASCVD procedure ever. (3) Removed pregnancy as a denominator exclusion.(4) Added denominator exception for patients with documentation of a medical reason for not being prescribed statin therapy. (5) Updated hospice indicator and palliative care definitions. (6) Updated medication taxonomy BGP PQA STATIN MEDS.
    • HIV Screening: Removed POV codes 042.0 through 044.9 and R75 from HIV definition.

CRS 2023 Documentation

CRS 2023 (v23.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 1.4 MB]

CRS 2023 (v23.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 966 KB]

Selected Measures Report Performance Measure List and Definitions [PDF - 1.9 MB]

Elder Care Report Performance Measure List and Definitions [PDF - 993 KB]

IPC Measures Report Performance Measure List and Definitions [PDF - 600 KB]